Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type i receptor internalization

Oncogene

Volumn 35, Issue 3, 2016, Pages 389-401

  Hwangbo, C ^a   Tae, N ^a   Lee, S ^a   Kim, O ^a   Park, O K ^b   Kim, J ^a   Kwon, S H ^b   Lee, J H ^a  

^a Kangwon National University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SYNTENIN; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

BIOSYNTHESIS; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UBIQUITINATION;

CAVEOLIN 1; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SYNTENINS; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITINATION;

EID: 84955754788     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.100     Document Type: Article

References (44)

1. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF- family signalling. Nature 2003; 425: 577-584.
2. Attisano L, Wrana JL. Signal transduction by the TGF- superfamily. Science 2002; 296: 1646-1647.
3. Zavadil J, Bottinger EP. TGF- and epithelial-to-mesenchymal transitions. Oncogene 2005; 24: 5764-5774.
4. Bierie B, Moses HL. Tumour microenvironment: TGF-: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006; 6: 506-520.
5. Zhang YE. Non-Smad pathways in TGF- signaling. Cell Res 2009; 19: 128-139.
6. Itoh S, ten Dijke P. Negative regulation of TGF- receptor/Smad signal transduction. Curr Opin Cell Biol 2007; 19: 176-184.
7. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF- receptor function. Trends Cell Biol 2009; 19: 385-394.
8. Chen YG. Endocytic regulation of TGF- signaling. Cell Res 2009; 19: 58-70.
9. Lonn P, Moren A, Raja E, Dahl M, Moustakas A. Regulating the stability of TGF receptors and Smads. Cell Res 2009; 19: 21-35.
10. Derynck R, Akhurst RJ, Balmain A. TGF- signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-129.
11. Zavadil J, Bottinger EP. TGF- and epithelial-to-mesenchymal transitions. Oncogene 2005; 24: 5764-5774.
12. Christofori G. New signals from the invasive front. Nature 2006; 441: 444-450.
13. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
14. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-558.
15. Xu J, Lamouille S, Derynck R. TGF-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-172.
16. Koroll M, Rathjen FG, Volkmer H. The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self associating activity. J Biol Chem 2001; 276: 10646-10654.
17. Beekman JM, Coffer PJ. The ins and outs of syntenin, a multifunctional intracellular adaptor protein. J Cell Sci 2008; 121: 1349-1355.
18. Sarkar D, Boukerche H, Su ZZ, Fisher PB. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res 2008; 68: 3087-3093.
19. Zimmermann P, Meerschaert K, Reekmans G, Leenaerts I, Small JV, Vandekerckhove J et al. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane. Mol Cell 2002; 9: 1215-1225.
20. Kang BS, Cooper DR, Devedjiev Y, Derewenda U, Derewenda ZS. PDZ tandem of human syntenin: crystal structure and functional properties. Structure 2003; 11: 459-468.
21. Grembecka J, Cierpicki T, Devedjiev Y, Derewenda U, Kang BS, Bushweller JH et al. The binding of the PDZ tandem of syntenin to target proteins. Biochemistry 2006; 45: 3674-3683.
22. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A et al. Syndecansyntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012; 14: 677-685.
23. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, Lee JH. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 2002; 21: 4080-4088.
24. Dasgupta S, Menezes ME, Das SK, Emdad L, Janjic A, Bhatia S et al. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin Cancer Res 2013; 19: 4621-4633.
25. Yang Y, Hong Q, Shi P, Liu Z, Luo J, Shao Z. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival. Breast Cancer Res 2013; 15: R50.
26. Kegelman TP, Das SK, Hu B, Bacolod MD, Fuller CE, Menezes ME et al. MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro Oncol 2014; 16: 50-61.
27. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-B. Cancer Res 2007; 67: 1812-1822.
28. Boukerche H, Su ZZ, Prévot C, Sarkar D, Fisher PB. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci USA 2008; 105: 15914-15919.
29. Hwangbo C, Kim J, Lee JJ, Lee JH. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase C and the PDZ adapter protein mda-9/Syntenin. Cancer Res 2010; 70: 1645-1655.
30. Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M et al. FAM/USP9x, a deubiquitinating enzyme essential for TGF signaling, controls Smad4 monoubiquitination. Cell 2009; 136: 123-135.
31. Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118: 277-279.
32. Shi J, Wang DM, Wang CM, Hu Y, Liu AH, Zhang YL et al. Insulin receptor substrate-1 suppresses transforming growth factor-1-mediated epithelialmesenchymal transition. Cancer Res 2009; 69: 7180-7187.
33. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T et al. Smurf1 interacts with transforming growth factor- type I receptor through Smad7 and induces receptor degradation. J Biol Chem 2001; 276: 12477-12480.
34. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF receptor for degradation. Mol Cell 2000; 6: 1365-1375.
35. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Böttinger EP, Lisanti MP. Caveolin-1 regulates transforming growth factor (TGF)-/SMAD signaling through an interaction with the TGF- type I receptor. J Biol Chem 2001; 276: 6727-6738.
36. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981.
37. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002; 110: 669-672.
38. Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, Di Fiore PP. Clathrinmediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell 2008; 15: 209-219.
39. Penheiter SG, Mitchell H, Garamszegi N, Edens M, Doré JJ Jr, Leof EB. Internalizationdependent and-independent requirements for transforming growth factor- receptor signaling via the Smad pathway. Mol Cell Biol 2002; 22: 4750-4759.
40. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF- receptor signalling and turnover. Nat Cell Biol 2003; 5: 410-421.
41. Zhao B, Wang Q, Du J, Luo S, Xia J, Chen YG. PICK1 promotes caveolin-dependent degradation of TGF- type I receptor. Cell Res 2012; 22: 1467-1478.
42. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 2007; 8: 128-140.
43. Browman DT, Hoegg MB, Robbins SM. The SPFH domain-containing proteins: more than lipid raft markers. Trends Cell Biol 2007; 17: 394-402.
44. Van Rheenen J, Achame EM, Janssen H, Calafat J, Jalink K. PIP2 signaling in lipid domains: a critical re-evaluation. EMBO J 2005; 24: 1664-1673.